COMPARISON OF THE ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS AND ORAL LORCAINIDE IN PATIENTS WITH RECURRENT VENTRICULAR-TACHYCARDIA

被引：23

作者：

ECHT, DS

MITCHELL, LB

KATES, RE

WINKLE, RA

机构：

来源：

关键词：

D O I：

10.1161/01.CIR.68.2.392

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：392 / 399

页数：8

共 16 条

[1] BAR FW, 1981, BRIT HEART J, V45, P292
[2] BREITHARDT G, 1981, Z KARDIOL, V70, P530
[3] CARMELIET E, 1978, ARCH INT PHARMACOD T, V231, P104
[4] INITIAL CLINICAL EXPERIENCE OF LORCAINIDE (RO 13-1042), A NEW ANTIARRHYTHMIC AGENT
COCCO, G
STROZZI, C
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (02) : 105 - 109
[5] ELECTROPHYSIOLOGY OF ORAL ENCAINIDE
JACKMAN, WM
ZIPES, DP
NACCARELLI, GV
RINKENBERGER, RL
HEGER, JJ
PRYSTOWSKY, EN
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (05) : 1270 - 1278
[6] JOSEPHSON ME, 1979, CLIN CARDIAC ELECTRO, P23
[7] ELECTRO-PHYSIOLOGICAL ACTIONS OF LORCAINIDE IN PATIENTS WITH CARDIAC DISEASE
KASPER, W
MEINERTZ, T
KERSTING, F
LOLLGEN, H
LANG, K
JUST, H
[J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1979, 1 (03) : 343 - 352
[8] KATES RE, 1982, CLIN PHARM THER, V33, P28
[9] KEEFE DL, 1982, CIRCULATION, V66, P69
[10] RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED CROSSOVER TRIAL DOCUMENTING ORAL LORCAINIDE EFFICACY IN SUPPRESSION OF SYMPTOMATIC VENTRICULAR TACHYARRHYTHMIAS
KEEFE, DL
PETERS, F
WINKLE, RA
[J]. AMERICAN HEART JOURNAL, 1982, 103 (04) : 511 - 518